Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Crown Castle International Corp (CCI) vs Viatris Inc (VTRS) Price & Performance

Crown Castle International CorpTrade
Viatris IncTrade

Price performance (Past 24H)

Key statistics

Crown Castle International Corp vs Viatris Inc — how do they compare? Crown Castle International Corp trades at $79.87 (market cap $34.50B), while Viatris Inc trades at $16.26 (market cap $18.99B). The key difference: Crown Castle International Corp is the larger of the two by market cap, and Crown Castle International Corp pays the higher dividend (5.38%). Which is the better fit depends on your goals.

CCIVTRS
Market Cap
$34.50B$18.99B
Sector
Real EstateHealth
52-Week High
$113.91$17.39
52-Week Low
$74.92$8.74
Enterprise Value
$64.33B$31.20B
Dividend Yield
5.38%2.94%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Crown Castle International Corp

Crown Castle (CCI) trades at $79.84, up 0.23% on the day, with a bearish technical signal from moving averages. The company reported mixed Q1 2026 earnings, missing EPS estimates, but maintains strong profitability with a 73.82% gross margin. Recent news highlights its pure-play U.S. tower focus and upcoming Q2 2026 earnings call on July 22, 2026.

CCI presents a turnaround opportunity with analyst consensus targeting $97.33, implying 22% upside, but faces risks from high debt levels and volatile earnings. The stock's negative equity and bearish technicals warrant caution despite attractive dividend yield and cost reduction initiatives.

Viatris Inc

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

About Crown Castle International Corp

Crown Castle International owns and leases roughly 40,000 cell towers in the United States. It also owns more than 85,000 route miles of fiber. It leases space on its towers to wireless service providers, which install equipment on the towers to support their wireless networks. The company's fiber is primarily leased by wireless service providers to set up small-cell network infrastructure and by enterprises for their internal connection needs. Crown Castle's towers and fiber are predominantly located in the largest U.S. cities. The company has a very concentrated customer base, with more than 70% of its revenue coming from the big three U.S. mobile carriers. Crown Castle operates as a real estate investment trust.

Read more on CCI

About Viatris Inc

Formed by the combination of Mylan and Pfizer's Upjohn business in 2020, Viatris is one of the world's largest generic drug manufacturers, with a substantial off-patent branded drug portfolio. Its portfolio consists of more than 1,400 molecules with penetration across most of the developed world and in select emerging markets. The company's branded drug portfolio consists of off-patent blockbuster drugs that continue to generate strong sales, including Lipitor, Norvasc, Lyrica, Viagra, and EpiPen. While global competition has facilitated the commodification of small-molecule generic drugs, the company has demonstrated an edge over peers in its ability to manufacture complex generics (for example, generic Advair and Copaxone).

Read more on VTRS